Core Concepts
Disparities in cancer screening programs globally, with Europe leading in organization and performance.
Abstract
The analysis of global cancer screening programs reveals significant differences between high- and low-income countries. Europe stands out for its well-organized screening programs, particularly in colorectal cancer. The CanScreen5 project aims to collect and analyze data from 84 countries on 5 continents to assess the performance of breast, cervical, and colorectal cancer screening programs. Key findings include variations in examination coverage, with the UK leading in breast cancer screening, Sweden in cervical cancer, and the Netherlands in colorectal cancer. Europe mandates national breast cancer screening programs, mainly using mammography, while Asia and the Americas lag behind. All continents have laws for cervical screening, but screening services vary in cost and availability. Colorectal cancer screening programs predominantly use the faecal immunochemical test, with varying levels of screening coverage globally.
Stats
"Examination coverage for breast cancer is highest in the United Kingdom (84%), for cervical cancer is highest in Sweden (86.3%), and for colorectal cancer is highest in the Netherlands (64.5%)."
"Nearly half of the breast cancer screening programmes in Europe are mandated by laws to provide national screening programmes."
"Most colorectal cancer screening programmes used the faecal immunochemical test."
Quotes
"Low- and middle-income countries in particular need to make more intensive efforts to measure performance of cancer screening systematically to ensure that the programmes are more effective and efficient in saving lives from common cancers." - Partha Basu